Mark Halvorson

Array ( [id] => 6562019 [patent_doc_number] => 20100272742 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-28 [patent_title] => 'NOVEL SERPENTINE TRANSMEMBRANE ANTIGENS EXPRESSED IN HUMAN CANCERS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/761759 [patent_app_country] => US [patent_app_date] => 2010-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 22297 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20100272742.pdf [firstpage_image] =>[orig_patent_app_number] => 12761759 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6538031 [patent_doc_number] => 20100204269 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'Compounds and methods for treatment of chemotherapy-induced anemia' [patent_app_type] => utility [patent_app_number] => 12/798856 [patent_app_country] => US [patent_app_date] => 2010-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 34559 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20100204269.pdf [firstpage_image] =>[orig_patent_app_number] => 12798856 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6070155 [patent_doc_number] => 20110045005 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR OF HEMATOPOIETIC ORIGIN' [patent_app_type] => utility [patent_app_number] => 12/756149 [patent_app_country] => US [patent_app_date] => 2010-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 185 [patent_figures_cnt] => 185 [patent_no_of_words] => 106425 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20110045005.pdf [firstpage_image] =>[orig_patent_app_number] => 12756149 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8209910 [patent_doc_number] => 20120129168 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-24 [patent_title] => 'TUMOR MARKER AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/263015 [patent_app_country] => US [patent_app_date] => 2010-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7119 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20120129168.pdf [firstpage_image] =>[orig_patent_app_number] => 13263015 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9468414 [patent_doc_number] => 08722045 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-05-13 [patent_title] => 'Cell and therapeutical and diagnostical methods based thereon' [patent_app_type] => utility [patent_app_number] => 13/262088 [patent_app_country] => US [patent_app_date] => 2010-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 8618 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13262088 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8797084 [patent_doc_number] => 08435951 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-07 [patent_title] => 'Treating neoplasms with neurotoxin' [patent_app_type] => utility [patent_app_number] => 12/725955 [patent_app_country] => US [patent_app_date] => 2010-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14625 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12725955 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6054603 [patent_doc_number] => 20110110963 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'GENE ENCODING LABYRINTHIN, A MARKER FOR CANCER' [patent_app_type] => utility [patent_app_number] => 12/725404 [patent_app_country] => US [patent_app_date] => 2010-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8472 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20110110963.pdf [firstpage_image] =>[orig_patent_app_number] => 12725404 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8055929 [patent_doc_number] => 20120077696 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'SOLUBLE HLA COMPLEXES FOR USE IN DISEASE DIAGNOSIS' [patent_app_type] => utility [patent_app_number] => 13/256712 [patent_app_country] => US [patent_app_date] => 2010-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 24267 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20120077696.pdf [firstpage_image] =>[orig_patent_app_number] => 13256712 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6423921 [patent_doc_number] => 20100168027 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'BPC-1: A SECRETED BRAIN-SPECIFIC PROTEIN EXPRESSED AND SECRETED BY PROSTATE AND BLADDER CANCER CELLS' [patent_app_type] => utility [patent_app_number] => 12/718821 [patent_app_country] => US [patent_app_date] => 2010-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 22969 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0168/20100168027.pdf [firstpage_image] =>[orig_patent_app_number] => 12718821 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8081673 [patent_doc_number] => 08148154 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-03 [patent_title] => 'Method for preparation of single chain antibodies' [patent_app_type] => utility [patent_app_number] => 12/709848 [patent_app_country] => US [patent_app_date] => 2010-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 37077 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/148/08148154.pdf [firstpage_image] =>[orig_patent_app_number] => 12709848 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6289850 [patent_doc_number] => 20100158899 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'PROTEIN FORMULATION' [patent_app_type] => utility [patent_app_number] => 12/698347 [patent_app_country] => US [patent_app_date] => 2010-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 17433 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20100158899.pdf [firstpage_image] =>[orig_patent_app_number] => 12698347 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8375180 [patent_doc_number] => 08257971 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-04 [patent_title] => 'In vitro tumor angiogenesis model' [patent_app_type] => utility [patent_app_number] => 12/697700 [patent_app_country] => US [patent_app_date] => 2010-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2978 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12697700 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6588978 [patent_doc_number] => 20100291594 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'ErbB Surface Receptor Complexes as Biomarkers' [patent_app_type] => utility [patent_app_number] => 12/689144 [patent_app_country] => US [patent_app_date] => 2010-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 26564 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20100291594.pdf [firstpage_image] =>[orig_patent_app_number] => 12689144 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7510911 [patent_doc_number] => 20110256633 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'Secretory Granules and Granulogenic Factors as a Target for Cancer Treatment' [patent_app_type] => utility [patent_app_number] => 12/740160 [patent_app_country] => US [patent_app_date] => 2009-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 15511 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20110256633.pdf [firstpage_image] =>[orig_patent_app_number] => 12740160 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6374552 [patent_doc_number] => 20100081151 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-01 [patent_title] => 'BIOMARKERS FOR EARLY DETECTION OF OVARIAN CANCER' [patent_app_type] => utility [patent_app_number] => 12/630458 [patent_app_country] => US [patent_app_date] => 2009-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 24440 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20100081151.pdf [firstpage_image] =>[orig_patent_app_number] => 12630458 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8189621 [patent_doc_number] => 08183357 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-22 [patent_title] => 'Antibodies that bind to EphA2 and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 12/627335 [patent_app_country] => US [patent_app_date] => 2009-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 27316 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/183/08183357.pdf [firstpage_image] =>[orig_patent_app_number] => 12627335 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6627282 [patent_doc_number] => 20100172939 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'Treating neoplasms with neurotoxin' [patent_app_type] => utility [patent_app_number] => 12/592540 [patent_app_country] => US [patent_app_date] => 2009-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 22203 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20100172939.pdf [firstpage_image] =>[orig_patent_app_number] => 12592540 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6046768 [patent_doc_number] => 20110206703 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-25 [patent_title] => 'GENE SIGNATURE FOR PREDICTING PROGNOSIS OF PATIENTS WITH SOLID TUMORS' [patent_app_type] => utility [patent_app_number] => 13/127701 [patent_app_country] => US [patent_app_date] => 2009-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 34987 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0206/20110206703.pdf [firstpage_image] =>[orig_patent_app_number] => 13127701 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6055075 [patent_doc_number] => 20110111435 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'Detecting Cell Surface Markers' [patent_app_type] => utility [patent_app_number] => 12/613798 [patent_app_country] => US [patent_app_date] => 2009-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 15629 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20110111435.pdf [firstpage_image] =>[orig_patent_app_number] => 12613798 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7977939 [patent_doc_number] => 08071717 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-06 [patent_title] => 'Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/589647 [patent_app_country] => US [patent_app_date] => 2009-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8691 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/071/08071717.pdf [firstpage_image] =>[orig_patent_app_number] => 12589647 [rel_patent_id] =>[rel_patent_doc_number] =>)